Potential therapeutic applications of recombinant, invasive E. coli

Gene Therapy

Volumn 11, Issue 15, 2004, Pages 1224-1233

  Critchley, R J ^a   Jezzard, S ^a   Radford, K J ^a,c   Goussard, S ^b   Lemoine, N R ^a   Grillot Courvalin, C ^b   Vassaux, G ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b INSTITUT PASTEUR   (France)

^c MATER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Gene delivery; Invasive; Prodrug activation; Protein delivery; Recombinant E. coli

Indexed keywords

BETA1 INTEGRIN; ESCHERICHIA COLI PROTEIN; LISTERIOLYSIN; RECOMBINANT PROTEIN; ADHESIN; ANTINEOPLASTIC AGENT; BACTERIAL PROTEIN; FLUOROURACIL; HYBRID PROTEIN; INVASIN, YERSINIA; PRODRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL MEMBRANE; CELL POPULATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOSOL; DENDRITIC CELL; EOSINOPHIL; ESCHERICHIA COLI; EXPRESSION VECTOR; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENETIC CODE; GENETIC RECOMBINATION; HOST CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LISTERIA MONOCYTOGENES; MACROPHAGE ACTIVATION; MAMMAL CELL; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHAGOSOME; PRIORITY JOURNAL; PROTEIN FUNCTION; YERSINIA PSEUDOTUBERCULOSIS; ANIMAL; BACTERIUM TRANSFORMATION; CELL LINE; CELL STRAIN CACO 2; EXPERIMENTAL MELANOMA; GENE THERAPY; GENE VECTOR; GENETICS; HELA CELL; IMMUNOLOGY; METABOLISM; METHODOLOGY; MICROBIOLOGY; NEOPLASM; PHAGOCYTE; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; LISTERIA; LISTERIA MONOCYTOGENES; MAMMALIA; YERSINIA; YERSINIA PSEUDOTUBERCULOSIS;

ADHESINS, BACTERIAL; ANIMALS; ANTINEOPLASTIC AGENTS; BACTERIAL PROTEINS; CACO-2 CELLS; CELL LINE; DENDRITIC CELLS; EOSINOPHILS; ESCHERICHIA COLI; FLUOROURACIL; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HELA CELLS; HUMANS; MELANOMA, EXPERIMENTAL; MICE; NEOPLASMS; PHAGOCYTES; PRODRUGS; RECOMBINANT FUSION PROTEINS; TRANSFORMATION, BACTERIAL;

EID: 1642322636     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3302281     Document Type: Article

References (41)

1. Naut HC. The Beneficial Effects of Bacterial Infections on Host Resistance to Cancer: End Result in 449 Cases, Monograph 8, 2nd edn. Cancer Research Institute Inc.: New York, 1980.
2. Mose JR, Mose G. Oncolysis by Clostridia. Activity of Clostridium butyricum (M-55) and other non-pathogenic Clostridia against the Ehrlich carcinoma. Cancer Res 1964; 24: 212-216.
3. Thiele EH, Arison RN, Boxer GE. Oncolysis by Clostridia. Effects of Clostridia and chemotherapeutic agents on rodent tumours. Cancer Res 1964; 24: 222-231.
4. Engelbart K, Gericke D. Oncolysis by Clostridia. Transplanted tumours of the hamster. Cancer Res 1964; 24: 239-243.
5. Carey RW et al. Clostridial oncolysis in humans. Eur J Cancer 1967; 3: 37-46.
6. Pawelek JM, Low KB, Bermudes D. Tumour-targeted Salmonella as a novel anti-cancer vector. Cancer Res 1997; 57: 4537-4544.
7. Low KB et al. Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumour-targeting in vivo. Nat Biotechnol 1999; 17: 37-41.
8. Theys J et al. Specific targeting of cytosine deaminase to solid tumours by engineered Clostridium acetobutylicum. Cancer Gene Ther 2001; 8: 294-297.
9. Nuyts S et al. Radio-responsive recA promoter significantly increases TNFα production in recombinant Clostridia after 2 Gy irradiation. Gene Therapy 2001; 8: 1197-1201.
10. Liu SC, Minton NP, Giacca AJ, Brown JM. Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumours hypoxia/necrosis. Gene Therapy 2002; 9: 291-296.
11. Toso JF et al. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol 2002; 20: 142-152.
12. Grillot-Courvalin C et al. Functional gene transfer from intracellular bacteria to mammalian cells. Nat Biotech 1998; 16: 862-866.
13. Grillot-Courvalin C, Goussard S, Courvalin P. Bacteria as gene delivery vectors for mammalian cells. Curr Opin Biotechnol 1999; 10: 477-481.
14. Isberg RR, Leong JM. Multiple β1-integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Cell 1990; 60: 861-867.
15. Cossart P et al. Listeriolysin-O is essential for virulence of Listeria monocytogenes: direct evidence obtained by gene complementation. Infect Immun 1989; 57: 3629-3636.
16. Beauregard KE, Lee KD, Collier RJ, Swanson JA. pH dependent perforation of macrophage phagosomes by listeriolysin-O from Listeria monocytogenes. J Exp Med 1997; 186: 1159-1163.
17. Provada CJ, Lee KD. Bacterial pore-forming hemolysins and their use in the cytosolic delivery of macromolecules. Adv Drug Deliv Rev 2000; 41: 209-221.
18. Fassler R et al. Lack of β1-integrin gene in embryonic stem cells affects morphology, adhesion and migration but not integration into the inner cell mass of blastocysts. J Cell Biol 1995; 128: 979-988.
19. Wennerberg K et al. 1-integrin-dependent and -independent polymerisation of fibronectin. J Cell Biol 1996; 132: 227-238.
20. Sorscher EJ et al. Tumour cell bystander killing in colonic carcinoma utilising the Escherichia coli DeoD gene to generate toxic purines. Gene Therapy 1994; 1: 233-238.
21. Hughes BW et al. Cell to cell contact is not required for bystander cell killing by Escherichia coli purine nucleoside phosphorylase. J Biol Chem 1998; 273: 2322-2328.
22. Lockett LJ, Molloy PL, Russell PJ, Both GW. Relative efficiency of tumour cell killing in vitro by two enzyme-prodrug systems delivered by identical adenovirus vectors. Clin Cancer Res 1997; 3: 2075-2080.
23. Kanai F et al. Adenovirus-mediated transduction of the E. coli uracil phosphoribosyltransferase gene sensitises cancer cells to low concentrations of 5-fluorouracil. Cancer Res 1998; 58: 1946-1951.
24. Koyama F et al. Adenoviral transfer of E coli uracil phosphoribosyltransferase (UPRT) gene to modulate the sensitivity of the human colon cancer cells to 5-fluorouracil. Eur J Cancer 2000; 36: 2403-2410.
25. Jiang W et al. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 1995; 375: 151-155.
26. Higgins DE, Shastri N, Portnoy DA. Delivery of protein to the cytosol of macrophages using Escherichia coli K-12. Mol Microbiol 1999; 31: 1631-1641.
27. Radford KJ et al. A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy. Gene Therapy 2002; 9: 1455-1463.
28. Radford KJ et al. Recombinant E. coli efficiently delivers antigen and maturation signals to human dendritic cells: presentation of MART-1 to CD8+ T-cells. Int J Cancer 2003; 105: 811-819.
29. Gallucci S, Lolkema ML, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 1999; 5: 1249-1255.
30. Hemmi H et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408: 740-745.
31. Matzinger P. An innate sense of danger. Semin Immunol 1998; 10: 399-415.
32. Melero I, Vile RG, Colombo MP. Feeding dendritic cells with tumor antigens: self-service buffet or a la carte? Gene Therapy 2000; 7: 1167-1170.
33. Zutter MM, Sun H, Santoro SA. Altered integrin expression and the malignant phenotype: the contribution of multiple integrated integrin receptors. J Mammary Gland Biol Neoplasia 1998; 3: 109-116.
34. Bereta MK et al. Construction of a recombinant Salmonella vector displaying anti-CEA antibody: a novel method for targeting colon-adenocarcinomas. Proceedings of the 93rd Annual Meeting of the American Association for Cancer Research, Vol. 43, 2002, Abstract 3288.
35. Dang LH et al. Combination bacteriolytic therapy for the treatment of experimental tumours. Proc Natl Acad Sci USA 2001; 98: 15155-15160.
36. Pawelek JM et al. Salmonella pathogenicity island-2 and anticancer activity in mice. Cancer Gene Ther 2002; 9: 813-818.
37. Black ME, Newcomb TG, Wilson HMP, Loeb LA. Creation of a drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy. Proc Natl Acad Sci USA 1996; 93: 3525-3529.
38. Andersen PS, Smith JM, Mygind B. Characterization of the upp gene encoding uracil phosphoribosyltransferase of Escherichia coli K12. Eur J Biochem 1992; 204: 51-56.
39. Mosmann T. Rapid colometric assay for cellular growth and survival: applications to proliferation and cytotoxicity assays. J Immun Methods 1983; 65: 55-63.
40. Vassaux G, Huxley C. A dicistronic construct allows easy detection of human CFTR expression from YAC DNA in human cells. Nucleic Acids Res 1997; 20: 4167-4168.
41. Anderson-McKay JE, Both GW, Simpson GW. Stereo-selective synthesis of 6-methyl-9-(2-deoxy-β-D-erithro-pentofuranosyl)-purine. Nucleosides Nucleotides 1996; 15: 1307-1313.